Synonymous mutation in  TP53  results in a cryptic splice site affecting its DNA‐binding site in an adolescent with two primary sarcomas | Zendy

Austin Frances | Zendy; Oyarbide Usua | Zendy; Massey Gita | Zendy; Grimes Margaret | Zendy; Corey Seth J. | Zendy

Premium

Synonymous mutation in TP53 results in a cryptic splice site affecting its DNA‐binding site in an adolescent with two primary sarcomas

Author(s) -

Austin Frances,

Oyarbide Usua,

Massey Gita,

Grimes Margaret,

Corey Seth J.

Publication year - 2017

Publication title -

pediatric blood and cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.116

H-Index - 105

eISSN - 1545-5017

pISSN - 1545-5009

DOI - 10.1002/pbc.26584

Subject(s) - genetics , germline mutation , germline , splice site mutation , splice , mutation , dna , binding site , biology , rna splicing , medicine , gene , rna

Pathologic variants in TP53 are known risk factors for the development of cancer. We report a 17‐year‐old male who presented with two primary sarcomas. Germline sequencing revealed a novel TP53 c.672 G>A mutation. Sequencing revealed wild‐type TP53 in the parents, and there was no history of cancer in first‐degree relatives. This de novo synonymous germline mutation results in a 5′ cryptic splice site that is bound by U1, resulting in a shift of the splice site by 5 base pairs. The frame shift results in a truncated protein at residue 246, which disrupts the DNA‐binding domain of p53.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research